SCHEMBL23913186

SCHEMBL23913186

CC1CC2=C(CCC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11054767 0.90 KMT2A (0.35)
SCHEMBL4311225 0.77 CYP2A6 (0.32)
SCHEMBL2044296 0.69 KMT2A (0.34)
SCHEMBL1659708 0.69 KMT2A (0.34)
SCHEMBL2045753 0.69 KMT2A (0.34)
SCHEMBL8141014 0.67
SCHEMBL20627368 0.67
SCHEMBL875668 0.64
SCHEMBL1495223 0.64
SCHEMBL19745458 0.63 TRIM24 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3386981-B1 HETEROCYCLES USEFUL AS ANTI-CANCER AGENTS HANGZHOU INNOGATE PHARMA CO LTD (CN) 2021-10-13 EP disclosed